These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16109553)

  • 1. [Killing effect of Photofrin-Herceptin immunoconjugate on tumor cell lines in vitro].
    Qian XY; Luo RC; Li LB; Liao WJ; Luo YL
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):975-8. PubMed ID: 16109553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Killing effect of 131I-Herceptin on breast cancer cell lines in vitro].
    Lin J; Luo RC; Li AM; Zhang JY; Lü CW; Yan X
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):663-6. PubMed ID: 15958303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preparation of hematoporphyrin-herceptin photoimmunoconjugate for photoimmunotherapy].
    Chen L; Luo RC; Li LB; Yan X; Ding XM
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):355-7. PubMed ID: 16546747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of interferon-gamma on Her-2/neu expression and antitumor activity of 131I-Herceptin in breast cancer cell lines].
    Fan YX; Luo RC; Fang YX; Yan X; Lu CW
    Ai Zheng; 2006 Apr; 25(4):443-6. PubMed ID: 16613677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of HER-2/neu in uterine serous papillary cancer.
    Santin AD; Bellone S; Gokden M; Palmieri M; Dunn D; Agha J; Roman JJ; Hutchins L; Pecorelli S; O'Brien T; Cannon MJ; Parham GP
    Clin Cancer Res; 2002 May; 8(5):1271-9. PubMed ID: 12006548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.
    Cuello M; Ettenberg SA; Clark AS; Keane MM; Posner RH; Nau MM; Dennis PA; Lipkowitz S
    Cancer Res; 2001 Jun; 61(12):4892-900. PubMed ID: 11406568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Killing effect of sequential Herceptin and adriamycin treatment on breast cancer cell line in vitro].
    Tan K; Fan YX; Miao JX; Lü CW; Yan X; Luo RC
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):234-6. PubMed ID: 16503541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo.
    Jerome L; Alami N; Belanger S; Page V; Yu Q; Paterson J; Shiry L; Pegram M; Leyland-Jones B
    Cancer Res; 2006 Jul; 66(14):7245-52. PubMed ID: 16849573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [188Re-labeled herceptin inhibits proliferation of breast cancer cell line SKBR-3 in vitro].
    Li GP; Zhang YF; Wang YX
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1455-7. PubMed ID: 17062351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability.
    Kang SH; Kang KW; Kim KH; Kwon B; Kim SK; Lee HY; Kong SY; Lee ES; Jang SG; Yoo BC
    BMC Cancer; 2008 Oct; 8():286. PubMed ID: 18834540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of breast cancer cells overexpressing HER2/neu by 213Bi-Herceptin radioimmunoconjugate.
    Zhang DY; Li Y; Rizvi SM; Qu C; Kearsley J; Allen BJ
    Cancer Lett; 2005 Feb; 218(2):181-90. PubMed ID: 15670895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines.
    Gong SJ; Jin CJ; Rha SY; Chung HC
    Cancer Lett; 2004 Oct; 214(2):215-24. PubMed ID: 15363548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA strand breaks and cell cycle perturbation in herceptin treated breast cancer cell lines.
    Mayfield S; Vaughn JP; Kute TE
    Breast Cancer Res Treat; 2001 Nov; 70(2):123-9. PubMed ID: 11768602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo.
    Guan H; Jia SF; Zhou Z; Stewart J; Kleinerman ES
    Clin Cancer Res; 2005 Mar; 11(5):2008-17. PubMed ID: 15756027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trastuzumab-induced HER reprogramming in "resistant" breast carcinoma cells.
    Narayan M; Wilken JA; Harris LN; Baron AT; Kimbler KD; Maihle NJ
    Cancer Res; 2009 Mar; 69(6):2191-4. PubMed ID: 19276389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line.
    Nagy P; Friedländer E; Tanner M; Kapanen AI; Carraway KL; Isola J; Jovin TM
    Cancer Res; 2005 Jan; 65(2):473-82. PubMed ID: 15695389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).
    Sliwkowski MX; Lofgren JA; Lewis GD; Hotaling TE; Fendly BM; Fox JA
    Semin Oncol; 1999 Aug; 26(4 Suppl 12):60-70. PubMed ID: 10482195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia.
    Zhang J; Dewilde AH; Chinn P; Foreman A; Barry S; Kanne D; Braunhut SJ
    Int J Hyperthermia; 2011; 27(7):682-97. PubMed ID: 21992561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene].
    Guo MG; Jiang MH; Yang Q; Li YM; Cui ZF; Li LF; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1147-51. PubMed ID: 15387973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.